What OATS does for a damaged ankle

Being told you have a cartilage lesion in your ankle can feel unexpectedly serious — ankle problems are easy to dismiss as lingering sprain damage. An osteochondral lesion of the talus (OLT) goes deeper than that: it involves injury to both the cartilage surface of the talus (the bone that forms the floor of the ankle joint) and the bone immediately beneath it. Most OLTs develop after a single traumatic event or a series of ankle sprains that gradually wear through the joint surface, leaving a pocket of damaged or unsupported tissue.

OATS — osteochondral autograft transfer surgery — addresses this by transplanting a cylindrical plug of healthy cartilage and its underlying bone from a lower-load area of the patient's own knee directly into the ankle defect. Because the graft includes living bone and the natural cartilage that grew on top of it, the repaired surface contains hyaline-like tissue: structurally closer to the original joint cartilage than the scar tissue that forms after simpler procedures.

That distinction matters clinically. Bone marrow stimulation (microfracture) is appropriate for smaller, less complex lesions, but the fibrocartilage it produces tends to break down within two to three years and can damage the subchondral bone plate in the process — making any subsequent repair harder. For lesions larger than roughly 1 cm², cystic defects, or lesions that have already been treated with microfracture, OATS is generally preferred. The American Orthopaedic Foot and Ankle Society (AOFAS) endorses primary autologous osteochondral transfer as the superior option over bone marrow stimulation for large or cystic OLTs.

One practical advantage is that OATS is a single-stage procedure: one operation places the graft, rather than the two-stage process required by cell-based techniques.

The four phases of recovery after OATS

Recovery follows a predictable four-phase arc, and knowing what each phase involves makes the timeline far easier to plan around.

Phase 1 — Surgery to six weeks: protected rest

For the first six weeks you will be non-weightbearing or on partial weight only, using crutches and wearing a cast or walking boot. The priority at this stage is osseointegration: the transplanted bone plug needs to fuse with the surrounding talar bone before it can tolerate load. Rushing this phase risks graft failure, so the restriction is biological, not precautionary.

Phase 2 — Six weeks: walking again, physiotherapy begins

By the six-week mark, full weightbearing without crutches is permitted. Formal physiotherapy starts at the same point, with your physiotherapist working on your walking pattern (gait retraining) and introducing active and passive range-of-motion exercises for the ankle simultaneously.

Phase 3 — Four to six months: building fitness and sport-specific skills

Once basic movement and strength are restored, rehabilitation shifts to proprioceptive training, balance work, and sport-specific conditioning. Light, low-impact running is typically introduced toward the end of this window — when the graft has sufficient structural integrity to tolerate repetitive loading.

Phase 4 — Six to twelve months: returning to full sport

Progressive return to competitive sport, pivoting movements, and contact loading follows over the second half of the year. Twelve months is the standard clinical threshold before cutting and contact sports are cleared.

The six-to-twelve-month window before full sport can feel long. For context, accelerated protocols used in knee OATS have produced safe returns in as few as 83 days in competitive athletes — suggesting the ankle timeline may be set conservatively to protect a more complex graft site and the joint mechanics of weightbearing. Evidence supports the caution rather than arbitrary timekeeping.

Return to sport rates and what the evidence shows

Published series consistently place the return-to-sport rate after OATS for ankle OLT at approximately 85–90%. That figure, however, covers a range of outcomes: 65–80% of patients go on to reach their pre-injury competitive level, while a smaller proportion return to sport but at reduced intensity. For anyone planning a return to competitive activity, the realistic expectation is a strong majority achieve it — but not every patient gets back to exactly where they started.

Functional scores back this up. AOFAS ankle-hindfoot scores typically rise from the 50–60 range before surgery into the 80s or 90s post-operatively — a shift that represents genuine, clinically meaningful improvement in pain, stability, and daily function.

Long-term durability

The most rigorous available data comes from a cohort with a mean follow-up of 138.9 months (just over 11 years), involving 39 patients treated for large osteochondral lesions. At the 10-year mark, graft survival stood at 94.9%, and FAOS (Foot and Ankle Outcome Score) improved from 51.9 before surgery to 75.3 — a statistically significant gain (P<0.001). For a procedure addressing large or cystic lesions that other techniques struggle with, those figures are notable for their durability.

Understanding the complication rate

The same cohort recorded a 43.6% overall complication rate at 10 years — a figure that warrants context rather than alarm. The most common adverse event was anterior ankle impingement, affecting 25.6% of patients. Most complications were manageable rather than catastrophic. The failure rate — meaning graft loss requiring revision or conversion — was 5.1%.

Two factors are specifically linked to failure: a history of prior bone marrow stimulation (microfracture) before the OATS procedure, and the appearance of cysts around the graft on post-operative MRI. Lesion size also matters — larger defects are associated with less favourable functional scores, which is why pre-surgical counselling on realistic expectations is important.

Donor site morbidity: the knee harvest tradeoff

Every OATS procedure creates two wounds: the ankle being repaired, and the knee where the graft plugs are harvested. That second site — typically a low-load area of the femoral condyle — is the primary distinguishing tradeoff of OATS compared with cell-based or scaffold techniques, which leave the knee untouched.

A meta-analysis of knee-to-talus procedures estimated donor-site morbidity at between 6.7% and 10.8%, with persistent knee pain and mechanical symptoms being the main concerns. Crucially, this transfer direction — knee to ankle — carries a higher donor-site risk than equivalent knee-to-knee OATS. Risk also scales with the harvest: larger plugs and multiple-plug harvests (as used in mosaicplasty) increase the likelihood of problems, and the gaps between multiple plugs carry an additional concern around fibrocartilage ingrowth rather than hyaline-like tissue fill.

One established mitigation is backfilling the harvest site with allograft material, which evidence suggests significantly reduces post-operative knee pain.

An emerging alternative: harvesting from the talus itself

For medial talar lesions, a newer approach harvests from the ipsilateral lateral talar articular facet instead of the knee, removing the donor-site risk at the knee entirely. Early data are encouraging — AOFAS scores in one series improved from 55.4 before surgery to 92.1 at one-year follow-up (p=0.001), with mean follow-up of nearly 65 months. The caveat is that the evidence base for this technique remains considerably smaller than for established knee harvest methods, so it is not yet a universal option.

Knowing about donor-site risk is not a reason to avoid OATS — it is a reason to have a specific conversation with your surgeon before the procedure about harvest site, plug number, and whether backfill or an alternative harvest approach is appropriate for your anatomy.

Who OATS is and is not right for

Deciding whether OATS is appropriate depends on three broad factors: how non-surgical management has gone, the size and character of the lesion, and individual health and anatomy.

When surgery enters the picture

Non-operative care — activity modification, bracing, physiotherapy, and protected weight-bearing — resolves symptoms in roughly half of patients with acute or non-displaced osteochondral lesions of the talus. For those who remain symptomatic after a genuine trial of conservative management, surgical options enter the conversation, and OATS is typically considered once that threshold has been crossed.

Lesion size and the decision hierarchy

Defect dimensions shape which procedure is offered. Single-plug OAT is generally appropriate for lesions in the 1–2 cm² range. Mosaicplasty — using multiple smaller plugs — can address areas up to approximately 4 cm², though the multi-plug approach introduces additional considerations around tissue fill between plugs, as noted in the section on donor-site morbidity. Very large or extensively cystic defects may instead point towards osteochondral allograft, which removes the harvest-size constraints inherent to autograft.

Relative contraindications

BMI above 40, age over 50, and significant existing knee osteoarthritis are recognised relative contraindications — particularly pertinent because the knee is the standard harvest site. These factors shift the risk-benefit calculation without being absolute bars, and each warrants a specific discussion at consultation.

Typical candidate and prior surgical history

The procedure best fits younger, active individuals with a post-traumatic focal lesion who have not responded to conservative care. A history of prior microfracture at the same site is important pre-surgical information: the outcomes data link it to a higher risk of complications, making it a counselling priority — though it does not automatically rule OATS out.

Finding a specialist for ankle OATS in the UK

Surgical volume and experience matter for OATS outcomes: the procedure involves both precise graft harvesting at the knee and technically demanding placement into a small talar defect. Choosing a surgeon with specific experience in osteochondral ankle surgery — rather than general foot-and-ankle or orthopaedic practice — is a practical step worth prioritising.

Search MSK, a UK musculoskeletal specialist directory, lists ankle cartilage surgeons across the country who offer OATS and related osteochondral procedures — you can filter by region and specialty to find a clinician near you.

For a first consultation, it helps to arrive with your MRI report (ideally recent, with lesion size documented), a clear account of any prior treatment — particularly whether microfracture has been performed at the same site — and an honest picture of your knee health, since that directly affects donor-site planning. Those three things allow a specialist to move straight to the prognostic discussion rather than spending the appointment reconstructing your history.